Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Do modern total knee replacements offer better value for money? A health economic analysis.

Hamilton DF, Clement ND, Burnett R, Patton JT, Moran M, Howie CR, Simpson AH, Gaston P.

Int Orthop. 2013 Nov;37(11):2147-52. doi: 10.1007/s00264-013-1992-4. Epub 2013 Jul 9.

2.

Comparative outcomes and cost-utility following surgical treatment of focal lumbar spinal stenosis compared with osteoarthritis of the hip or knee: part 2--estimated lifetime incremental cost-utility ratios.

Rampersaud YR, Tso P, Walker KR, Lewis SJ, Davey JR, Mahomed NN, Coyte PC.

Spine J. 2014 Feb 1;14(2):244-54. doi: 10.1016/j.spinee.2013.11.011. Epub 2013 Nov 12.

PMID:
24239803
3.

A randomised controlled trial of the clinical effectiveness and cost-effectiveness of different knee prostheses: the Knee Arthroplasty Trial (KAT).

Murray DW, MacLennan GS, Breeman S, Dakin HA, Johnston L, Campbell MK, Gray AM, Fiddian N, Fitzpatrick R, Morris RW, Grant AM; KAT group.

Health Technol Assess. 2014 Mar;18(19):1-235, vii-viii. doi: 10.3310/hta18190.

4.

Placing a price on medical device innovation: the example of total knee arthroplasty.

Suter LG, Paltiel AD, Rome BN, Solomon DH, Thornhill TS, Abrams SK, Katz JN, Losina E.

PLoS One. 2013 May 6;8(5):e62709. doi: 10.1371/journal.pone.0062709. Print 2013.

5.

Mobile bearing vs fixed bearing prostheses for posterior cruciate retaining total knee arthroplasty for postoperative functional status in patients with osteoarthritis and rheumatoid arthritis.

Hofstede SN, Nouta KA, Jacobs W, van Hooff ML, Wymenga AB, Pijls BG, Nelissen RG, Marang-van de Mheen PJ.

Cochrane Database Syst Rev. 2015 Feb 4;(2):CD003130. doi: 10.1002/14651858.CD003130.pub3. Review.

PMID:
25650566
6.

Comparison of the EuroQol and short form 6D in Singapore multiethnic Asian knee osteoarthritis patients scheduled for total knee replacement.

Xie F, Li SC, Luo N, Lo NN, Yeo SJ, Yang KY, Fong KY, Thumboo J.

Arthritis Rheum. 2007 Aug 15;57(6):1043-9.

7.

Cost-effectiveness and economic impact of the KineSpring ® Knee Implant System in the treatment for knee osteoarthritis.

Li CS, Seeger T, Auhuber TC, Bhandari M.

Knee Surg Sports Traumatol Arthrosc. 2013 Nov;21(11):2629-37. doi: 10.1007/s00167-013-2427-x. Epub 2013 Feb 10.

PMID:
23397420
8.

Cost-effectiveness and economic impact of the KineSpring® Knee Implant System in the treatment of knee osteoarthritis in Italy.

Marcacci M, Zaffagnini S, Li CS, Bhandari M.

J Long Term Eff Med Implants. 2013;23(2-3):211-22.

PMID:
24579860
9.
10.

Cost Effectiveness Analysis of Knee Osteoarthritis Treatment.

Stan G, Orban H, Orban C.

Chirurgia (Bucur). 2015 Jul-Aug;110(4):368-74.

11.

Predicting the cost-effectiveness of total hip and knee replacement: a health economic analysis.

Jenkins PJ, Clement ND, Hamilton DF, Gaston P, Patton JT, Howie CR.

Bone Joint J. 2013 Jan;95-B(1):115-21. doi: 10.1302/0301-620X.95B1.29835.

PMID:
23307684
12.

Cost effectiveness of patellofemoral versus total knee arthroplasty in younger patients.

Chawla H, Nwachukwu BU, van der List JP, Eggman AA, Pearle AD, Ghomrawi HM.

Bone Joint J. 2017 Aug;99-B(8):1028-1036. doi: 10.1302/0301-620X.99B8.BJJ-2016-1032.R1.

PMID:
28768779
13.

Impact of total knee replacement practice: cost effectiveness analysis of data from the Osteoarthritis Initiative.

Ferket BS, Feldman Z, Zhou J, Oei EH, Bierma-Zeinstra SM, Mazumdar M.

BMJ. 2017 Mar 28;356:j1131. doi: 10.1136/bmj.j1131.

14.

Cost-Effectiveness of Bariatric Surgery Prior to Total Knee Arthroplasty in the Morbidly Obese: A Computer Model-Based Evaluation.

McLawhorn AS, Southren D, Wang YC, Marx RG, Dodwell ER.

J Bone Joint Surg Am. 2016 Jan 20;98(2):e6. doi: 10.2106/JBJS.N.00416.

PMID:
26791039
15.

Economic evaluation of access to musculoskeletal care: the case of waiting for total knee arthroplasty.

Mather RC 3rd, Hug KT, Orlando LA, Watters TS, Koenig L, Nunley RM, Bolognesi MP.

BMC Musculoskelet Disord. 2014 Jan 18;15:22. doi: 10.1186/1471-2474-15-22.

16.

Knee Joint Distraction Compared to Total Knee Arthroplasty for Treatment of End Stage Osteoarthritis: Simulating Long-Term Outcomes and Cost-Effectiveness.

van der Woude JA, Nair SC, Custers RJ, van Laar JM, Kuchuck NO, Lafeber FP, Welsing PM.

PLoS One. 2016 May 12;11(5):e0155524. doi: 10.1371/journal.pone.0155524. eCollection 2016.

18.

SF-6D and EQ-5D result in widely divergent incremental cost-effectiveness ratios in a clinical trial of older women: implications for health policy decisions.

Davis JC, Liu-Ambrose T, Khan KM, Robertson MC, Marra CA.

Osteoporos Int. 2012 Jul;23(7):1849-57. doi: 10.1007/s00198-011-1770-3. Epub 2011 Sep 10.

19.

Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.

Haentjens P, De Groote K, Annemans L.

Arch Orthop Trauma Surg. 2004 Oct;124(8):507-17. Epub 2004 Sep 10.

PMID:
15365714
20.

Effect of age on cost-effectiveness of unicompartmental knee arthroplasty compared with total knee arthroplasty in the U.S.

Ghomrawi HM, Eggman AA, Pearle AD.

J Bone Joint Surg Am. 2015 Mar 4;97(5):396-402. doi: 10.2106/JBJS.N.00169.

Supplemental Content

Support Center